Table 4.
Factors associated with anxiety symptoms in seniors.
| Anxiety symptoms (yes/no) |
|||||||
|---|---|---|---|---|---|---|---|
| Univariable logistic regression |
Multivariable logistic regression |
||||||
| OR | 95% CI | p-Value | OR | 95% CI | p-Value | ||
| Gender | |||||||
| Male | Ref. | ||||||
| Female | 3.74 | 2.12–6.62 | 0.000 | 2.77 | 1.53–5.00 | 0.001 | |
| Age (years) | 0.98 | 0.94–1.02 | 0.371 | 0.96 | 0.92–1.00 | 0.078 | |
| NUTS II | |||||||
| Norte | Ref. | Ref. | |||||
| Centro | 0.99 | 0.63–1.57 | 0.982 | 0.98 | 0.60–1.60 | 0.939 | |
| Lisboa | 0.92 | 0.29–3.00 | 0.897 | 0.97 | 0.37–2.54 | 0.949 | |
| Alentejo | 0.76 | 0.37–1.57 | 0.462 | 0.79 | 0.36–1.73 | 0.553 | |
| Algarve | 0.65 | 0.18–2.42 | 0.525 | 0.93 | 0.23–3.78 | 0.918 | |
| Azores | 0.66 | 0.28–1.58 | 0.356 | 1.14 | 0.41–3.18 | 0.796 | |
| Madeira | 0.87 | 0.46–1.66 | 0.683 | 0.91 | 0.48–1.75 | 0.785 | |
| Live alone (Y/N) | 1.25 | 0.75–2.07 | 0.389 | ||||
| Level of education | |||||||
| ≤4 years | 3.09 | 1.72–5.54 | 0.000 | 2.30 | 1.22–4.36 | 0.010 | |
| >4 years | Ref. | ||||||
| BMI | |||||||
| Underweight | Ref. | ||||||
| Normal | 0.50 | 0.10–2.45 | 0.390 | ||||
| Overweight | 0.58 | 0.11–3.05 | 0.521 | ||||
| Obese | 0.51 | 0.10–2.52 | 0.407 | ||||
| Alcohol intake | |||||||
| Never | Ref. | ||||||
| Daily intake | 0.35 | 0.20–0.62 | <0.001 | ||||
| Occasionally | 0.65 | 0.33–1.30 | 0.224 | ||||
| Smoke | |||||||
| Never | Ref. | ||||||
| Past | 0.82 | 0.33–2.06 | 0.680 | ||||
| Present | 0.40 | 0.15–1.06 | 0.066 | ||||
| No regular physical exercise | 0.85 | 0.48–1.53 | 0.590 | ||||
| High blood pressure (Y/N) | 2.03 | 1.18–3.50 | 0.011 | ||||
| Diabetes (Y/N) | 0.94 | 0.56–1.58 | 0.808 | ||||
| High cholesterol level (Y/N) | 1.23 | 0.69–2.20 | 0.489 | ||||
| Pulmonar disease (Y/N) | 1.64 | 0.94–2.85 | 0.080 | ||||
| Cardiac disease (Y/N) | 1.50 | 0.89–2.52 | 0.127 | ||||
| Gastrointestinal diseases (Y/N) | 1.80 | 1.03–3.13 | 0.039 | ||||
| Neurologic diseases (Y/N) | 1.85 | 0.93–3.67 | 0.080 | ||||
| Allergies (Y/N) | 2.43 | 1.23–4.79 | 0.011 | 2.02 | 1.14–3.55 | 0.015 | |
| Neoplasic disease (Y/N) | 0.89 | 0.46–1.72 | 0.732 | ||||
| Thyroid disease (Y/N) | 2.51 | 1.50–4.20 | <0.001 | ||||
| Hyperuricemia (Y/N) | 1.13 | 0.65–1.98 | 0.655 | ||||
| Rheumatic disease (Y/N) | 4.36 | 2.65–7.16 | <0.001 | 2.92 | 1.74–4.90 | <0.001 | |
HADS-A, Hospital Anxiety and Depression Scale—Anxiety subscale; OR, odds ratio; CI, confidence interval; HAQ, Health Assessment Questionnaire (0–3); EQ5D, European Quality of Life questionnaire five dimensions three levels (0–1); BMI, body mass index.
†p-Value ≤ 0.05; GoF (p = 0.287).